|
82
|
322
|
4bciA |
Structure of cdk9 in complex with cyclin t and a 2-amino-4-heteroaryl- pyrimidine inhibitor |
|
139
|
416
|
4aw2A |
Crystal structure of cdc42 binding protein kinase alpha (mrck alpha) |
|
85
|
303
|
4bdjA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
110
|
357
|
4awiA |
Human jnk1alpha kinase with 4-phenyl-7-azaindole ikk2 inhibitor. |
|
86
|
304
|
4bdaA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
148
|
470
|
4azvA |
Co-crystal structure of wbdd and kinase inhibitor gw435821x. |
|
85
|
307
|
4bdiA |
Fragment-based screening identifies a new area for inhibitor binding to checkpoint kinase 2 (chk2) |
|
141
|
434
|
4axdA |
Inositol 1,3,4,5,6-pentakisphosphate 2-kinase in complex with amppnp |
|
107
|
358
|
3zyaA |
Human p38 map kinase in complex with 2-amino-phenylamino- dibenzosuberone |
|
107
|
349
|
4afjA |
5-aryl-4-carboxamide-1,3-oxazoles: potent and selective gsk-3 inhibitors |
|
111
|
349
|
3zshA |
X-ray structure of p38alpha bound to scio-469 |
|
107
|
349
|
3zrlA |
Identification of 2-(4-pyridyl)thienopyridinones as gsk-3beta inhibitors |
|
91
|
304
|
4a9tA |
Crystal structure of human chk2 in complex with benzimidazole carboxamide inhibitor |
|
113
|
328
|
4anmA |
Complex of ck2 with a cdc7 inhibitor |
|
77
|
277
|
4a4xA |
Nek2-ede bound to cct248662 |
|
87
|
282
|
4an3A |
Crystal structures of human mek1 with carboxamide-based allosteric inhibitor xl518 (gdc-0973), or related analogs. |
|
93
|
286
|
3zzeA |
Crystal structure of c-met kinase domain in complex with n'-((3z)-4- chloro-7-methyl-2-oxo-1,2-dihydro-3h-indol-3-ylidene)-2-(4- hydroxyphenyl)propanohydrazide |
|
113
|
359
|
3zuvA |
Crystal structure of a designed selected ankyrin repeat protein in complex with the phosphorylated map kinase erk2 |
|
104
|
349
|
4a9yA |
P38alpha map kinase bound to cmpd 8 |
|
85
|
282
|
4anbA |
Crystal structures of human mek1 with carboxamide-based allosteric inhibitor xl518 (gdc-0973), or related analogs. |
|
96
|
308
|
4anlA |
Structure of g1269a mutant anaplastic lymphoma kinase |
|
72
|
270
|
3zxtA |
Dimeric structure of dapk-1 catalytic domain in complex with amppcp- mg |
|
78
|
277
|
4agwA |
Discovery of a small molecule type ii inhibitor of wild-type and gatekeeper mutants of bcr-abl, pdgfralpha, kit, and src kinases |
|
90
|
310
|
3zuuA |
The structure of ost1 (d160a, s175d) kinase in complex with gold |
|
102
|
344
|
3zu7A |
Crystal structure of a designed selected ankyrin repeat protein in complex with the map kinase erk2 |
|
103
|
348
|
3zrmA |
Identification of 2-(4-pyridyl)thienopyridinones as gsk-3beta inhibitors |
|
106
|
342
|
3zo1A |
The synthesis and evaluation of diazaspirocyclic protein kinase inhibitors |
|
94
|
307
|
4aaaA |
Crystal structure of the human cdkl2 kinase domain |
|
82
|
283
|
4a06A |
Human pdk1 kinase domain in complex with allosteric activator ps114 bound to the pif-pocket |
|
100
|
339
|
4ae6A |
Structure and function of the human sperm-specific isoform of protein kinase a (pka) catalytic subunit calpha 2 |
|
74
|
277
|
4afeA |
Nek2 bound to hybrid compound 21 |
|
88
|
270
|
3ztxA |
Aurora kinase selective inhibitors identified using a taxol-induced checkpoint sensitivity screen. |
|
94
|
339
|
4ae9A |
Structure and function of the human sperm-specific isoform of protein kinase a (pka) catalytic subunit c alpha 2 |
|
112
|
352
|
3zs5A |
Structural basis for kinase selectivity of three clinical p38alpha inhibitors |
|
80
|
290
|
4a4oA |
Crystal structure of polo-like kinase 1 in complex with a 2-(2-amino- pyrimidin-4-yl)-1,5,6,7-tetrahydro-pyrrolopyridin-4-one inhibitor |
|
90
|
282
|
4an2A |
Crystal structures of human mek1 with carboxamide-based allosteric inhibitor xl518 (gdc-0973), or related analogs. |
|
81
|
290
|
4a4lA |
Crystal structure of polo-like kinase 1 in complex with a 5-(2-amino- pyrimidin-4-yl)-1h-pyrrole inhibitor |
|
89
|
317
|
4agdA |
Crystal structure of vegfr2 (juxtamembrane and kinase domains) in complex with sunitinib (su11248) (n-2-diethylaminoethyl)-5-((z)-(5- fluoro-2-oxo-1h-indol-3-ylidene)methyl)-2,4-dimethyl-1h-pyrrole-3- carboxamide) |
|
77
|
284
|
4a07A |
Human pdk1 kinase domain in complex with allosteric activator ps171 bound to the pif-pocket |
|
95
|
350
|
4achA |
Gsk3b in complex with inhibitor |
|
106
|
347
|
3zsiA |
X-ray structure of p38alpha bound to vx-745 |
|
98
|
350
|
4accA |
Gsk3b in complex with inhibitor |
|
99
|
303
|
4apcA |
Crystal structure of human nima-related kinase 1 (nek1) |
|
104
|
349
|
3zrkA |
Identification of 2-(4-pyridyl)thienopyridinones as gsk-3beta inhibitors |
|
96
|
292
|
4appA |
Crystal structure of the human p21-activated kinase 4 in complex with (s)-n-(5-(3-benzyl-1-methylpiperazine-4-carbonyl)-6,6-dimethyl-1,4,5, 6-tetrahydropyrrolo(3,4-c)pyrazol-3-yl)-3-phenoxybenzamide |
|
107
|
344
|
3zo2A |
The synthesis and evaluation of diazaspirocyclic protein kinase inhibitors |
|
93
|
302
|
4a9sA |
Crystal structure of human chk2 in complex with benzimidazole carboxamide inhibitor |
|
95
|
293
|
3zxzA |
X-ray structure of pf-04217903 bound to the kinase domain of c-met |
|
100
|
303
|
4ag8A |
Crystal structure of the vegfr2 kinase domain in complex with axitinib (ag-013736) (n-methyl-2-(3-((e)-2-pyridin-2-yl-vinyl)-1h- indazol-6-ylsulfanyl)-benzamide) |
|
94
|
350
|
4acgA |
Gsk3b in complex with inhibitor |
